Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.6.2, updating the revision tag to reflect a software update rather than a change to study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling. New help/navigation sections were added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), the Intervention/Treatment heading was added (replacing the old 'Intervention / Treatment' heading), and the revision line was updated to 'Revision: v3.6.0'.SummaryDifference0.4%

- Check23 days agoChange DetectedA new revision label (v3.5.5) replaces the previous v3.5.4 on the study page, indicating an update to the record's metadata.SummaryDifference0.1%

- Check45 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, signaling a minor update to the site’s underlying tooling or documentation rather than to trial content.SummaryDifference0.1%

- Check52 days agoChange DetectedNew and removed dates indicate updates to the study record history, reflecting revisions to the registry timeline. This does not change the substantive aspects of the trial such as design, endpoints, or eligibility.SummaryDifference0.3%

- Check66 days agoChange DetectedThe page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, indicating a site software/content management update rather than a change to the study record.SummaryDifference0.1%

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.